TJ037130
/ TJ Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 21, 2026
A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=128 | Not yet recruiting | Sponsor: TJ Biopharma Co., Ltd.
New P1 trial • Endometrial Cancer • Gastric Cancer • Oncology • Ovarian Cancer • Solid Tumor • CLDN6
October 20, 2026
A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=128 | Recruiting | Sponsor: TJ Biopharma Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Endometrial Cancer • Gastric Cancer • Oncology • Ovarian Cancer • Solid Tumor • CLDN6
1 to 2
Of
2
Go to page
1